39 hasil untuk "Kaleb Michaud"
Menampilkan 1–20 · 0,82 detik · RSS
-
Artikel Jurnal
Associations Between Smartphone‐Derived Behavioral Data and Rheumatoid Arthritis Flares
Objective Rheumatoid arthritis (RA) features sporadic symptoms that intensify during flares, significantly affecting the quality of life. This study aimed to (1) characterize flare frequency and severity, (2) assess if short‐term changes in patient‐reported outcomes (PROs) signal RA flares, and (3)…
-
Artikel Jurnal
Probiotic Use and Psoriatic Arthritis Disease Activity
Objective Probiotics have been hypothesized to mediate inflammation through gut microbiome modulation. Spondyloarthropathies have subclinical gut inflammation associated with inflammatory disease that may benefit from probiotic use. We aimed to evaluate associations between probiotic use and…
-
Artikel Jurnal
Smartphone-based behavioral monitoring and patient-reported outcomes in adults with rheumatic and musculoskeletal disease
Abstract Background Rheumatic and musculoskeletal diseases (RMD) are associated with depression, fatigue, and disturbed sleep – symptoms that often impact behavior and activity. Patient reported outcomes (PROs) are a way of collecting information on the patient symptom experience directly from the…
-
Artikel Jurnal
Estimation of Minimally Important Differences and Patient Acceptable Symptom State Scores for the Patient‐Reported Outcomes Measurement Information System Pain Interference Short Form in Rheumatoid Arthritis
Objective Studies have supported the validity of the Patient‐Reported Outcomes Measurement Information System (PROMIS) Pain Interference (PI) scale in rheumatoid arthritis (RA). Here, we characterize minimally important differences (MIDs) and patient acceptable symptom state (PASS) values. Methods…
-
Artikel Jurnal
Risk factors for venous thromboembolism and atherosclerotic cardiovascular disease: do they differ in patients with rheumatoid arthritis?
Objective Venous thromboembolism (VTE) is an increasing concern in rheumatoid arthritis (RA) with little known about risk factors. We aimed to compare risk factors for unprovoked VTE and atherosclerotic cardiovascular disease (ASCVD) in patients with RA and to assess subsequent ASCVD risk after an…
-
Artikel Jurnal
The Impact of Asthma and Chronic Obstructive Pulmonary Disease (COPD) on Patient‐Reported Outcomes in Systemic Lupus Erythematosus (SLE)
Background Risk of asthma and chronic obstructive pulmonary disease (COPD) may be elevated in systemic lupus erythematosus (SLE), but little research has studied the impact of these conditions on SLE outcomes. We examined prevalence, incidence, and impact of self‐reported asthma and COPD in two…
-
Artikel Jurnal
First Cardiovascular Event in Rheumatoid Arthritis: Do Patients With Venous Thromboembolism Have a Different Risk Profile Than Patients With Atherosclerotic Cardiovascular Disease?
Mentor: Kaleb Michaud Program: Internal Medicine Type: Original Research Objective: To assess risk factors favoring VTE over ASCVD in patients with rheumatoid arthritis (RA). Methods: RA patients participating in FORWARD from 1998 through 2018 were assessed for incident nonfatal/fatal unprovoked…
-
Artikel Jurnal
The Burden of Glucocorticoids: Patterns of Use, Adverse Health Conditions, and Health Care Use in Two Cohorts With Systemic Lupus Erythematosus
Objective Glucocorticoids (GCs) can be beneficial from both clinical and patient perspectives, but side effects are well documented. We examined patterns of GC use over 15 years (2006–2021) and occurrence of adverse health conditions (AHCs) and health care use by GC exposure in two longitudinal…
-
Artikel Jurnal
Safety of abatacept compared with other biologic and conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: data from an observational study
Abstract Background To assess the risks of malignancies, infections and autoimmune diseases in patients with rheumatoid arthritis (RA) treated with abatacept compared with other biologic (b) disease-modifying antirheumatic drugs (DMARDs) or conventional synthetic (cs)DMARDs, in a US-wide…
-
Artikel Jurnal
Risk of Subsequent Atherosclerotic Cardiovascular Disease After the First Unprovoked Venous Thromboembolism in Patients With Rheumatoid Arthritis
Mentor: Kaleb Michaud Program: Internal Medicine Type: Original Research Objective: To determine the risk of subsequent ASCVD in RA patients with unprovoked first VTE Methods: RA patients with ≥1-year participation in FORWARD from 1998 through 2018 were assessed for incident nonfatal and fatal…
-
Artikel Jurnal
Side Effects of Methotrexate and Tumor Necrosis Factor Inhibitors: Differences in Tolerability Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis
Objective To examine the prevalence of side effects with methotrexate (MTX) and tumor necrosis factor inhibitors (TNFi) among patients with psoriatic arthritis (PsA) and rheumatoid arthritis (RA). Methods This retrospective analysis, conducted between January 2000 and January 2019, used data from…
-
Artikel Jurnal
Short Form 36 (SF-36) health survey questionnaire in health-related quality of life assessment in patients with inflammatory myopathies
Introduction: Idiopathic inflammatory myopathy (IIM) is a group of autoimmune diseases characterised by chronic skeletal muscle inflammation presenting as muscle weakness.1 Given chronic multi-system manifestations of IIM, which include skin rashes, interstitial lung disease, inflammatory…
-
Artikel Jurnal
Treatment Adherence and Adherence Patterns of Tofacitinib and Self‐Injectable TNFi Use in People with Rheumatoid Arthritis
Objective To assess tofacitinib and self‐injectable tumor necrosis factor inhibitor (TNFi) adherence using the Medication Event Monitoring System (MEMS) and characterize association with adherence in patients with rheumatoid arthritis (RA). Methods Eligible patients were enrolled from the Forward…
-
Artikel Jurnal
Risk of Serious Infection in Patients With Rheumatoid Arthritis Treated With Biologic Versus Nonbiologic Disease‐Modifying Antirheumatic Drugs
Objective The objective of this study is to examine the risk of serious infections (SIs) associated with biological disease‐modifying antirheumatic drugs (bDMARDs) compared with conventional synthetic disease‐modifying antirheumatic drugs (csDMARDs) in patients with rheumatoid arthritis (RA)…
-
Artikel Jurnal
Perspectives on Treatment Burden for Methotrexate and Tumor Necrosis Factor Inhibitors Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis: A Qualitative Study
Objective To describe patients’ perspectives on the burden associated with methotrexate (MTX) or tumor necrosis factor inhibitor (TNFi) use in psoriatic arthritis (PsA) and rheumatoid arthritis (RA). Methods Between May 2019 and March 2020, patients receiving MTX and/or a TNFi for either PsA or RA…
-
Artikel Jurnal
The Incidence, Prevalence and Burden of Gout in the Veterans Health Administration
Mentor: Ted Mikuls and Bryant England Program: Internal Medicine, Division of Rheumatology Type: Original Research Background: To determine the prevalence, incidence, and burden of gout in the Veterans Health Administration (VHA) from 2005–2014. Methods: We used national VHA data from…
-
Artikel Jurnal
Correlation of the Multi-Biomarker Disease Activity Score with Rheumatoid Arthritis Disease Activity Measures: A Systematic Review and Meta-Analysis
Mentor: Bryant England Program: Internal Medicine Background: There are conflicting reports on the validity of the multi-biomarker disease activity (MBDA) score to assess rheumatoid arthritis (RA) disease activity. We performed a systematic review of the MBDA and meta-analysis of the correlation…
-
Artikel Jurnal
Serious infection risk in rheumatoid arthritis compared with non-inflammatory rheumatic and musculoskeletal diseases: a US national cohort study
Objectives To identify serious infection (SI) risk by aetiology and site in patients with rheumatoid arthritis (RA) compared with those with non-inflammatory rheumatic and musculoskeletal diseases (NIRMD).Methods Patients participating in FORWARD from 2001 to 2016 were assessed for SIs; defined by…
-
Artikel Jurnal
Serious infection risk in older adults with RA receiving biologic or targeted synthetic DMARDs: the role of age at disease onset
Background: Older age is a risk factor for serious infection (SI) associated with biologic or targeted synthetic DMARDs (b/tsDMARDs) use in rheumatoid arthritis (RA). Among older adults with RA, one-third are diagnosed at ⩾60 years (late-onset RA, LORA), while others are diagnosed earlier…